首页> 外文期刊>Journal of Neurochemistry: Offical Journal of the International Society for Neurochemistry >Mutant SOD1-induced neuronal toxicity is mediated by increased mitochondrial superoxide levels.
【24h】

Mutant SOD1-induced neuronal toxicity is mediated by increased mitochondrial superoxide levels.

机译:突变的SOD1诱导的神经元毒性由线粒体超氧化物水平升高介导。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Amyotrophic lateral sclerosis (ALS), the most common motor neuron disease in adults, is characterized by the selective degeneration and death of motor neurons leading to progressive paralysis and eventually death. Approximately 20% of familial ALS cases are associated with mutations in SOD1, the gene encoding Cu/Zn-superoxide dismutase (CuZnSOD). Previously, we reported that overexpression of the mitochondrial antioxidant manganese superoxide dismutase (MnSOD or SOD2) attenuates cytotoxicity induced by expression of the G37R-SOD1 mutant in a human neuroblastoma cell culture model of ALS. In the present study, we extended these earlier findings using several different SOD1 mutants (G93C, G85R, and I113T). Additionally, we tested the hypothesis that mutant SOD1 increases mitochondrial-produced superoxide (O(2) (*-)) levels and that SOD2 overexpression protects neurons from mutant SOD1-induced toxicity by reducing O(2) (*-) levels in mitochondria. In the present study, we demonstrate that SOD2 overexpression markedly attenuates the neuronal toxicity induced by adenovirus-mediated expression of all four SOD1 mutants (G37R, G93C, G85R, or I113T) tested. Utilizing the mitochondrial-targeted O(2) (*-)-sensitive fluorogenic probe MitoSOX Red(TM), we observed a significant increase in mitochondrial O(2) (*-) levels in neural cells expressing mutant SOD1. These elevated O(2) (*-) levels in mitochondria were significantly diminished by the overexpression of SOD2. These data suggest that mitochondrial-produced O(2) (*-) radicals play a critical role in mutant SOD1-mediated neuronal toxicity and implicate mitochondrial-produced free radicals as potential therapeutic targets in ALS.
机译:肌萎缩性侧索硬化症(ALS)是成人中最常见的运动神经元疾病,其特征在于运动神经元的选择性变性和死亡导致进行性麻痹并最终导致死亡。家族性ALS病例中约有20%与SOD1突变有关,SOD1是编码Cu / Zn超氧化物歧化酶(CuZnSOD)的基因。以前,我们报道过,线粒体抗氧化剂锰超氧化物歧化酶(MnSOD或SOD2)的过表达减弱了在人的神经母细胞瘤细胞培养模型中G37R-SOD1突变体的表达所诱导的细胞毒性。在本研究中,我们使用几种不同的SOD1突变体(G93C,G85R和I113T)扩展了这些早期发现。此外,我们测试了以下假设:突变体SOD1增加线粒体产生的超氧化物(O(2)(*-))水平,并且SOD2过表达通过降低线粒体中O(2)(*-)水平来保护神经元免受突变SOD1诱导的毒性。 。在本研究中,我们证明了SOD2的过表达显着减弱了腺病毒介导的所有四个SOD1突变体(G37R,G93C,G85R或I113T)的表达所诱导的神经毒性。利用针对线粒体的O(2)(*-)敏感的荧光探针MitoSOX Red™,我们观察到表达突变型SOD1的神经细胞中线粒体O(2)(*-)的水平显着增加。线粒体中这些升高的O(2)(*-)水平通过SOD2的过表达而大大降低了。这些数据表明,线粒体产生的O(2)(*-)自由基在突变的SOD1介导的神经元毒性中发挥关键作用,并暗示线粒体产生的自由基作为ALS中的潜在治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号